Projectes Sanitaris I Socials S.A.
- Address
- Plaza Era S N La Roca Del Valles, 08430 Barcelona, Spain
Projectes Sanitaris I Socials S.A.
Projectes Sanitaris I Socials S.A. is a clinical research center specializing in vaccine development and metabolic disease management. The center demonstrates extensive expertise in conducting pivotal trials for preventive medicine and chronic disease treatment, with a particular focus on vulnerable populations including older adults and patients with complex metabolic disorders.
- Respiratory syncytial virus (RSV) vaccine research including revaccination strategies and immune response evaluation in adults aged 60 and above
- Advanced diabetes management studies comparing novel insulin therapies, including weekly insulin formulations and combination treatment approaches
- Herpes Zoster vaccine trials evaluating long-term efficacy and immunological persistence in elderly populations
The center's research portfolio emphasizes comparative effectiveness studies and non-inferiority trials, particularly in optimizing treatment regimens for Type 2 diabetes mellitus through innovative insulin delivery systems. Their work in glycemic control optimization includes evaluating dose-reduction strategies with combination therapies, as well as investigating next-generation once-weekly insulin formulations. Additionally, the center maintains a strong commitment to studying vaccine immunogenicity and safety profiles in geriatric populations, contributing valuable data to public health initiatives aimed at preventing serious infectious diseases in older adults.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Novo Nordisk A/S1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novo Nordisk A/S4trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Projectes Sanitaris I Socials S.A.
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Dose-Finding Study to Evaluate the Efficacy and Safety of Once-Weekly Subcutaneous NNC0662-0419 in Participants with Type 2 Diabetes | Novo Nordisk A/S | Phase II | Recruiting | Apr 2026 | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Semaglutide | 3 | Unknown | 2022-08-31 | 2026-04-28 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.